Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comprehensive NGS-based Analyses and Role of HCT in Patients of PhALL

ABSTRACT: Sequential NGS for PhALL

PROVIDER: PRJEB48507 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR7209170_1.fastq.gz	Fastqsanger.gz
	ERR7209170_2.fastq.gz	Fastqsanger.gz
	ERR7209180_1.fastq.gz	Fastqsanger.gz
	ERR7209180_2.fastq.gz	Fastqsanger.gz
	ERR7209190_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 316

Similar Datasets

A comprehensive assessment of a newly designed non-exonic SNP-based NGS panel for HRD detection

Project description:Ovarian cancer is a global problem, is typically diagnosed at a late stage and has no effective screening strategy. Platinum-based chemotherapy or Poly(ADP-ribose) polymerase inhibitors (PARPis) treatment are most frequently applied for ovarian cancer patients who are inoperable and in the advanced stage. The recognition of homologous recombination deficiency (HRD) as a biomarker to predict the effect of Platinum-based or PARPis treatment. WGS and WES can detect tumor HRD status but have several disadvantages which restrict their clinical application. My choice HRD CDx and Foundation Focus CDx are approved by FDA for HRD detection, however, whether they are applicable to the Chinese population or not is unknown. In this study, we created an SNP-based Tg-NGS panel to fill in gaps in Chinese patients’ HRD screening. Our results showed that the panel is cost and time-saving compared with WGS, but equivalent with SNP microarray on CNV and HRD detection. In summary, this newly developed kit is promising in clinical application to guide ovarian cancer and even other cancer types therapy.

2023-02-21 | GSE203509 | GEO

NGS based post-HCT monitoring of AML

Project description:Next-generation sequencing based post-transplant monitoring of acute myeloid leukemia

| PRJEB27619 | ENA

Chromosomal microarray analysis for validation of the NGS-based CNV detection results in clinical samples

Project description:In order to evaluate the performance of CNV detection in next-generation sequencing platform in varied sample types, we employed chromosomal microarray analysis (CMA) for validation of the samples with NGS-based detection results (NCBI Sequence Read Archive with accession number SRA296708). Besides array Comparative Genomics Hybridization (aCGH, Agilent) , we used a commerical SNP-array (Illumina) including early abortus, induced termination, prenatal samples and postnatal samples. CMA results were compared with NGS-based detection results. 100% consistency was obtained between NGS-based approach and CMA in pathogenic or likely pathogenic CNVs detection.

2015-10-01 | GSE73190 | GEO

OAT NGS sequence

Project description:NGS sequence

| PRJNA735443 | ENA

NGS-based pipeline for NIPGT-A

Project description:NGS-based pipeline for routine non-invasive pre-implantation genetic assessment in IVF

| PRJEB38821 | ENA

metagenomics NGS study

Project description:metagenomics NGS study

| PRJEB42456 | ENA

transformants NGS

Project description:transgenic plant analysis using NGS

| PRJEB12451 | ENA

A novel NGS-based method can improve the efficiency and sensitivity of Y2H screening with cDNA library

Project description:The NGS-based Y2H screening methods have been adopted to increase the efficiency and sensitivity, while reducing the labor and experimental cost of the canonical Y2H screening. However, most of NGS-based Y2H screening methods are suitable for well-constructed ORFeomes but not cDNA libraries. Thus, we developed a novel NGS-based Y2H screening method to accomplish a precise Y2H screening with cDNA libraries. With newly designed primers, we can distinguish and filter out those non-in-frame reads from all mapped reads, which facilitates the estimation of the interaction intensity between baits and preys.

2021-07-09 | GSE179488 | GEO

NGS data of ER+/HER2- breast carcinoma patients

Project description:NGS data of ER+/HER2- breast carcinoma patients

| PRJEB58369 | ENA

Representative NGS sequencing of metastatic colorectal cancer patients

Project description:Representative NGS sequencing of metastatic colorectal cancer patients

| PRJEB58429 | ENA